Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 04, 2026
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:34pm, Wednesday, 29'th Apr 2020
Exact Sciences (EXAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
04:34pm, Wednesday, 29'th Apr 2020
Exact Sciences (EXAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cerner (CERN) Q1 Earnings Beat Estimates, Revenues Miss
03:15pm, Wednesday, 29'th Apr 2020
Cerner (CERN) first-quarter results benefit from gains in Licensed software, Subscriptions and Professional and Managed services units, and international revenue growth.
Cerner (CERN) Q1 Earnings Beat Estimates, Revenues Miss
03:15pm, Wednesday, 29'th Apr 2020
Cerner (CERN) first-quarter results benefit from gains in Licensed software, Subscriptions and Professional and Managed services units, and international revenue growth.
DexCom (DXCM) Q1 Earnings and Revenues Surpass Estimates
03:13pm, Wednesday, 29'th Apr 2020
DexCom's (DXCM) first-quarter earnings benefit from solid segmental performance.
EXACT Sciences (EXAS) to Release Quarterly Earnings on Wednesday
06:46am, Wednesday, 29'th Apr 2020
EXACT Sciences (NASDAQ:EXAS) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, May 6th. Analysts expect the company to announce earnings of ($0.66) per share for
Is a Beat in Store for Avadel (AVDL) This Earnings Season?
04:55pm, Tuesday, 28'th Apr 2020
On Avadel's (AVDL) Q1 earnings call, investor focus will be on the company's lead candidate, FT218, currently being evaluated to treat excessive daytime sleepiness and cataplexy in narcolepsy patients
What's in Store for Unum Therapeutics' (UMRX) Q1 Earnings?
04:51pm, Tuesday, 28'th Apr 2020
During Unum Therapeutics' (UMRX) upcoming Q1 earnings call, investor focus will be on the company's progress pertaining to its preclinical program, BOXR1030, for treating solid tumor cancers.
Ecolab (ECL) Q1 Earnings and Revenues Surpass Estimates
03:25pm, Tuesday, 28'th Apr 2020
Strength in the Global Industrial and Institutional segments drives Ecolab's (ECL) first-quarter results.
Ecolab (ECL) Q1 Earnings and Revenues Surpass Estimates
03:25pm, Tuesday, 28'th Apr 2020
Strength in the Global Industrial and Institutional segments drives Ecolab's (ECL) first-quarter results.
Henry Schein (HSIC) to Report Q1 Earnings: What's in Store?
03:22pm, Tuesday, 28'th Apr 2020
Contribution from Henry Schein's (HSIC) medical business in the form of point-of-care antibody rapid test is likely to have boosted Q1 performance amid the coronavirus pandemic.
Henry Schein (HSIC) to Report Q1 Earnings: What's in Store?
03:22pm, Tuesday, 28'th Apr 2020
Contribution from Henry Schein's (HSIC) medical business in the form of point-of-care antibody rapid test is likely to have boosted Q1 performance amid the coronavirus pandemic.
EXACT Sciences Co. (NASDAQ:EXAS) Position Raised by EULAV Asset Management
12:26pm, Tuesday, 28'th Apr 2020
EULAV Asset Management raised its stake in EXACT Sciences Co. (NASDAQ:EXAS) by 30.3% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 236,501 shares of th
Cognios Capital LLC Lowers Stock Holdings in EXACT Sciences Co. (NASDAQ:EXAS)
10:10am, Tuesday, 28'th Apr 2020
Cognios Capital LLC lowered its stake in shares of EXACT Sciences Co. (NASDAQ:EXAS) by 7.6% during the first quarter, according to the company in its most recent disclosure with the Securities & Excha
Artemis Investment Management LLP Trims Position in EXACT Sciences Co. (NASDAQ:EXAS)
08:26am, Tuesday, 28'th Apr 2020
Artemis Investment Management LLP reduced its position in EXACT Sciences Co. (NASDAQ:EXAS) by 21.5% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 115,748 shares
